[HTML][HTML] KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
W Mi, Z Zheng, JD Lu, SQ Duan, J Zhang… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Pancreatic adenocarcinoma (PAAD) is a cancerous tumor with an
extremely poor 5-year survival rate. The exploration of biomarkers for the diagnosis and …
extremely poor 5-year survival rate. The exploration of biomarkers for the diagnosis and …
KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
W Mi, Z Zheng, JD Lu, SQ Duan… - World journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Pancreatic adenocarcinoma (PAAD) is a cancerous tumor with an extremely
poor 5-year survival rate. The exploration of biomarkers for the diagnosis and treatment of …
poor 5-year survival rate. The exploration of biomarkers for the diagnosis and treatment of …
KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6.
W Mi, Z Zheng, JD Lu, SQ Duan, J Zhang… - World Journal of …, 2022 - europepmc.org
Background Pancreatic adenocarcinoma (PAAD) is a cancerous tumor with an extremely
poor 5-year survival rate. The exploration of biomarkers for the diagnosis and treatment of …
poor 5-year survival rate. The exploration of biomarkers for the diagnosis and treatment of …
[HTML][HTML] KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
W Mi, Z Zheng, JD Lu, SQ Duan, J Zhang… - World Journal of …, 2022 - wjgnet.com
BACKGROUND Pancreatic adenocarcinoma (PAAD) is a cancerous tumor with an
extremely poor 5-year survival rate. The exploration of biomarkers for the diagnosis and …
extremely poor 5-year survival rate. The exploration of biomarkers for the diagnosis and …
KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
W Mi, Z Zheng, JD Lu, SQ Duan, J Zhang… - World Journal of …, 2022 - wjgnet.com
Author contributions: Mi W, Zheng Z, Lu JD, Duan SQ, Zhang J and Zhang HQ all contributed
equally to this work; Mi W, Zheng Z, Lu JD and Duan SQ designed the study; Zhang HQ, Yin …
equally to this work; Mi W, Zheng Z, Lu JD and Duan SQ designed the study; Zhang HQ, Yin …
WJGO
W Mi, Z Zheng, JD Lu, SQ Duan, J Zhang, HQ Zhang… - 2022 - europepmc.org
BACKGROUND Pancreatic adenocarcinoma (PAAD) is a cancerous tumor with an
extremely poor 5-year survival rate. The exploration of biomarkers for the diagnosis and …
extremely poor 5-year survival rate. The exploration of biomarkers for the diagnosis and …